Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Joe on +44 1494 818011 or joe@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Joe Moore
Operations Director
joe@zenopa.com
+44 1494 818011

Testimonials
Just wanted to say a huge thank you for all of the help and advice you gave me in the build up to my 2 interviews and ultimate success in gaining employment in my new role.
Julie, 2013

Laborie highlights success of injeTAK cystoscopic injection needle

8 August 2012 16:08 in Medical Company Product News


Laborie has shone a spotlight on the positive reaction its injeTAK cystoscopic injection needle has received from medical professionals to date.

The firm states that it has seen "tremendous growth" in usage of the innovative device since its introduction thanks to the unique features it offers, as well as its affordable price.

It is the first injection needle to offer unique depth control and functionality, with its design allowing physicians to inject rapidly with consistent depth to multiple points within the bladder.

Injections using the needle are safer and more comfortable than many comparable products, while its zero-millimetre setting protects the cystoscope when inserted or withdrawn.

The manufacturer added: "The laser-cut multisided needle guarantees precision puncture with minimal tissue damage, while the ergonomic design allows for easy adjustment and single-handed operation."

Earlier this year, Laborie announced that it will be maintaining its distribution arrangement for the BRS Bulbocavernosus Reflex System in North and South America.ADNFCR-8000103-ID-801424919-ADNFCR

Other news stories from 08/08/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



   
© Copyright 2013 Zenopa Ltd